Table 2. Correlation between TAB3 expression and its O-GlcNAcylation and the clinicopathologic features of TNBC.

Criteria	Case No.	TAB3		P	TAB3 O-GlcNAcylation		P
		High	Low		High	Low
Age
< 50	44	20	24	0.809	18	26	0.782
≥ 50	66	24	42		22	44
Size
≤ 2	72	22	50	0.024*	20	52	0.043*
> 2	38	22	16		21	17
Grade
I	50	7	33	0.145	5	35	0.097
II	45	24	21		21	24
III	15	13	2		10	5
Axillary lymph node status
N0	30	7	23	0.001*	5	25	0.013*
N1	48	18	30		16	32
N2	32	18	14		17	15